CompoAtlas

DSY Taurine 500mg Capsule

DSY Taurine 500mg Capsule : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

No point flagged by the rules applied to recognised ingredients.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
TAURINETAURINE[500 mg,640 mg]Taurine

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
MAL23056050NC
Type
Health supplement
Published status
PRODUCT APPROVED
Licence holder
CTA NUTRICEUTICALS (ASIA) SDN BHD
Manufacturer
HERBAL SCIENCE SDN. BHD.
Registration period starting
2023-05-16
Published validity end
2028-05-16

Original register data

View published fields and their variants
Active ingredients
TAURINE[500 mg,640 mg]
Valid until
2028-05-16
Registration date
2023-05-16
Published description
HEALTH SUPPLEMENT
Licence holder
CTA NUTRICEUTICALS (ASIA) SDN BHD
Producer
HERBAL SCIENCE SDN. BHD.
Published name
DSY Taurine 500mg Capsule
Published reference
2023030910645N
Registration number
MAL23056050NC
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL23056050NC

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • TAURINE
    Read the warning, when it applies and the studies cited

    TAURINE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Lopez Ramon et al. 2007; Seghieri et al. 2007).

    Sources cited by Health Canada (2)
    • López Ramón Y Cajal C, Ocampo Martínez R, Couceiro Naveira E, Martínez M. Amino acids in amniotic fluid in the 15th-16th weeks of gestation and preterm labor. The Journal of Maternal-Fetal & Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2007;20(3):225-231.
    • Seghieri G, Tesi F, Bianchi L, Loizzo A, Saccomanni G, Ghirlanda G, Anichini R, Franconi F. Taurine in women with a history of gestational diabetes. Diabetes Research and Clinical Practice 2007;76(2):187-192. PubMed

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 January 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “DSY Taurine 500mg Capsule”, https://compoatlas.com/en/supplements/malaysia/MAL23056050NC-dsy-taurine-500mg-capsule, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line